Retatrutide 50MG
$238.00
Retatrutide 50MG is a 50-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist. Researchers study retatrutide in preclinical and clinical settings related to incretin and glucagon receptor signaling and downstream metabolic endpoints. Studies have examined its pharmacology using receptor binding and pathway activation assays.
In Stock
Retatrutide 50MG is a 50-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist in research involving incretin and glucagon family receptors. Published studies have examined retatrutide using in vitro signaling models and in vivo pharmacology frameworks to characterize receptor engagement, exposure response relationships, and biomarker changes.
Retatrutide 50MG is of interest to researchers working on peptide hormone analog design, receptor selectivity, and metabolic disease models where GLP-1, GIP, and glucagon pathways are commonly evaluated. Analytical workflows often include identity confirmation by mass spectrometry and purity assessment by chromatography prior to experimental use.
- Specification: 50MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Masteron / Drostanolone Propionate 200mg/ml, 10 ml refers to drostanolone propionate, a synthetic androgen esterified with propionic acid and commonly studied as a dihydrotestosterone derived anabolic androgenic steroid. Researchers investigate drostanolone propionate in models involving androgen receptor activity, steroid metabolism, and structure activity relationships. Analytical work may also focus on identity confirmation and concentration verification in liquid preparations.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Semaglutide 30MG is a 30-milligram format of semaglutide, a synthetic GLP-1 receptor agonist peptide analogue. Researchers study semaglutide in the context of incretin signaling, glucose regulation pathways, and appetite related neuroendocrine models. It is a modified peptide designed to extend stability relative to native GLP-1.
In Stock
Trenbolone Hexahydrobenzyl Carbonate – 100mg/ml, 10ml is a specified format of trenbolone hexahydrobenzyl carbonate, a long ester derivative of trenbolone, a synthetic anabolic androgenic steroid (19 nor testosterone analogue). It is studied analytically in steroid ester profiling, reference standard comparison, and method development using chromatographic and mass spectrometric techniques.
In Stock
Winstrol 50mg/ml 10ml refers to a 50 milligram per millilitre, 10 millilitre format commonly associated with stanozolol, a synthetic anabolic androgenic steroid. In research settings, stanozolol has been examined for its interactions with androgen receptor signaling and anabolic androgenic structure activity relationships. Studies have also used it as a reference compound in analytical and anti doping method development.
In Stock
Trenbolone Enanthate (Tre) 200mg/ml 10ml is a concentration and volume format of trenbolone enanthate, a synthetic anabolic androgenic steroid and esterified analogue of trenbolone. Researchers may use trenbolone esters in laboratory work involving androgen receptor signaling, steroid metabolism, and analytical reference testing.
In Stock
Trenbolone Acetate 75Mg, Trenbolone Enanthate 125Mg – 200mg/ml, 10 ml is a combined format of trenbolone in two ester forms: acetate and enanthate. Trenbolone is a synthetic anabolic androgenic steroid derived from 19-nortestosterone and widely referenced in endocrine and receptor binding research. Studies have examined esterified trenbolone in the context of androgen receptor signaling, pharmacokinetics, and steroid structure activity relationships.
In Stock
Winstrol 100mg ml 10ml is a concentration and volume format commonly associated with stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers and analytical labs may examine stanozolol in contexts such as receptor binding assays, metabolic profiling, and method development for detection and quantification.
In Stock
Semaglutide 20MG is a 20 milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is a 31 amino acid peptide modified for extended stability, and it is widely used in laboratory work involving incretin signaling and metabolic regulation. Researchers study semaglutide in preclinical and translational settings related to glucose homeostasis, appetite pathways, and receptor pharmacology.
In Stock
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
